IXICO plc (GB:IXI) has released an update.
IXICO plc, a leader in neuroscience precision analytics, has announced the appointment of Bram Goorden as its new CEO, effective from 19 August 2024. With over 20 years of leadership experience in BioPharma and precision medicine, Goorden brings a wealth of knowledge, specifically in CNS (Central Nervous System) medicine and AI platform commercial strategies. He succeeds Giulio Cerroni, who is set to retire but will support the transition until the end of the year.
For further insights into GB:IXI stock, check out TipRanks’ Stock Analysis page.
